Robust Reduction of HBsAg and HDV RNA Levels with Low Risk for ALT Elevations in JNJ-73763989 Treated Patients with Chronic Hepatitis D (CHD) and Baseline HBsAg Levels below 10, 000 IU/ml: Part 2 of the REEF-D Study